Quick Answer
Tenaya Therapeutics, Inc. reported Total Assets of $146.92 million for fiscal year 2025.
Tenaya Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $146.92M | +22.5% |
| 2024 | $119.94M | -29.7% |
| 2023 | $170.51M | -38.9% |
| 2022 | $278.94M | -11.2% |
| 2021 | $314.19M | +112.1% |
| 2020 | $148.16M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $104.98M | -25.3% | -14.1% |
| June 30, 2025 | $122.15M | -25.1% | -15.1% |
| March 31, 2025 | $143.95M | -22.1% | +20.0% |
| December 31, 2024 | $119.94M | -29.7% | -14.7% |
| September 30, 2024 | $140.58M | -27.3% | -13.9% |
| June 30, 2024 | $163.19M | -26.1% | -11.7% |
| March 31, 2024 | $184.90M | -24.6% | +8.4% |
| December 31, 2023 | $170.51M | -38.9% | -11.8% |
- Tenaya Therapeutics, Inc. showed an increase of +22.5% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Tenaya Therapeutics, Inc.’s total assets has declined by 0.8% (from $148.16 million to $146.92 million).
- The most recent figure is from Tenaya Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 11, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: